Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1959 2
1960 1
1961 2
1963 1
1964 2
1968 1
1974 2
1975 2
1976 2
1977 1
1978 1
1979 2
1980 1
1981 3
1982 5
1983 3
1984 4
1985 8
1986 3
1987 6
1988 4
1991 4
1992 9
1993 3
1994 6
1995 5
1996 4
1997 8
1998 7
1999 8
2000 13
2001 15
2002 15
2003 19
2004 18
2005 11
2006 10
2007 18
2008 13
2009 9
2010 6
2011 5
2012 12
2013 26
2014 24
2015 13
2016 23
2017 23
2018 16
2019 22
2020 17
2021 24
2022 19
2023 15
2024 10
2025 11
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Results by year

Filters applied: . Clear all
Page 1
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer.
Singhal U, Jiang R, Proudfoot JA, Chase E, Suresh K, Davicioni E, Borza T, Zelefsky MJ, Davis BJ, Stish BJ, Karnes RJ, Freedland SJ, Terris MK, Aronson WJ, Cooperberg MR, Moraes FY, Berlin A, Deville C, Zaorsky NG, Roy S, Jia AY, Shoag JE, Jackson WC, Spratt DE, Schipper M, Morgan TM, Dess RT. Singhal U, et al. Among authors: davis bj. Prostate Cancer Prostatic Dis. 2025 Dec 9. doi: 10.1038/s41391-025-01062-8. Online ahead of print. Prostate Cancer Prostatic Dis. 2025. PMID: 41366130
Pharmacological enhancement of fear extinction.
Davis BJ, Rosenberg BM, Kearney MG, Treanor M, Craske MG, Barry TJ. Davis BJ, et al. Trends Cogn Sci. 2025 Jul 9:S1364-6613(25)00157-3. doi: 10.1016/j.tics.2025.06.011. Online ahead of print. Trends Cogn Sci. 2025. PMID: 40634208 Free article. Review.
ACR-ARS Practice Parameter for Image-Guided Radiation Therapy (IGRT).
Garsa A, Buckey CR, Davis BJ, Freedman L, Gros SAA, Hallemeier CL, Lo SS, Milano MT, Saeed H, Ye JC, Small W Jr, Schechter NR. Garsa A, et al. Among authors: davis bj. Am J Clin Oncol. 2025 Nov 1;48(11):529-539. doi: 10.1097/COC.0000000000001220. Epub 2025 Jun 20. Am J Clin Oncol. 2025. PMID: 40539501
Oblique line scan illumination enables expansive, accurate and sensitive single-protein measurements in solution and in living cells.
Driouchi A, Bretan M, Davis BJ, Heckert A, Seeger M, Silva MB, Forrest WSR, Hsiung J, Tan J, Yang H, McSwiggen DT, Song L, Sule A, Abaie B, Chen H, Chhun B, Conroy B, Elliott LA, Gonzalez E, Ilkov F, Isaacs J, Labaria G, Lagana M, Larsen DD, Margolin B, Nguyen MK, Park E, Rine J, Tang Y, Vana M, Wilkey A, Zhang Z, Basham S, Ho JJ, Johnson S, Klammer AA, Lin K, Darzacq X, Betzig E, Berman RT, Anderson DJ. Driouchi A, et al. Among authors: davis bj. Nat Methods. 2025 Mar;22(3):559-568. doi: 10.1038/s41592-025-02594-6. Epub 2025 Feb 18. Nat Methods. 2025. PMID: 39966678 Free PMC article.
Five-Year Outcomes of Moderately Hypofractionated Proton Therapy Incorporating Elective Pelvic Nodal Irradiation for High-Risk Prostate Cancer.
Choo R, Hillman DW, Mitchell C, Daniels T, Vargas C, Rwigema JC, Corbin K, Keole S, Vora S, Merrell K, Stish B, Pisansky TM, Davis BJ, Amundson A, Wong W. Choo R, et al. Among authors: davis bj. Int J Radiat Oncol Biol Phys. 2025 May 1;122(1):99-108. doi: 10.1016/j.ijrobp.2024.11.115. Epub 2024 Dec 11. Int J Radiat Oncol Biol Phys. 2025. PMID: 39672515 Clinical Trial.
461 results